Skip to Content

RN5 (Rizatriptan benzoate 5 mg (base))

Pill imprint RN5 has been identified as Rizatriptan benzoate 5 mg (base).

Rizatriptan is used in the treatment of migraine and belongs to the drug class antimigraine agents. Risk cannot be ruled out during pregnancy. Rizatriptan 5 mg (base) is not a controlled substance under the Controlled Substance Act (CSA).

Rizatriptan benzoate 5 mg (base) RN5
Discount Card Promo
Rizatriptan benzoate
Imprint:
RN5
Strength:
5 mg (base)
Color:
Pink
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Antimigraine agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-1403
Inactive Ingredients:
lactose monohydrate
magnesium stearate
microcrystalline cellulose
corn starch
ferric oxide red

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide